InChI=1S/C15H21NO2/c1- 2- 7- 16- 8- 9- 18- 15- 13- 10- 12(17) 5- 3- 11(13) 4- 6- 14(15) 16/h3,5,10,14- 15,17H,2,4,6- 9H2,1H3/t14- ,15- /m1/s1 |
JCSREICEMHWFAY-HUUCEWRRSA-N |
[H][C@@]12CCC3=C(C=C(O)C=C3)[C@@]1([H])OCCN2CCC |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
dopamine agonist
A drug that binds to and activates dopamine receptors.
|
|
antiparkinson drug
A drug used in the treatment of Parkinson's disease.
dopamine agonist
A drug that binds to and activates dopamine receptors.
anticonvulsant
A drug used to prevent seizures or reduce their severity.
|
|
View more via ChEBI Ontology
(4aR,10bR)- 4- propyl- 3,4,4a,5,6,10b- hexahydro- 2H- naphtho[1,2- b][1,4]oxazin- 9- ol
|
naxagolida
|
WHO MedNet
|
naxagolide
|
WHO MedNet
|
naxagolide
|
WHO MedNet
|
naxagolidum
|
WHO MedNet
|
(+)-4-propyl-9-hydroxynaphthoxazine
|
ChemIDplus
|
(+)-PHNO
|
ChemIDplus
|
(4aR- trans)- 3,4,4a,5,6,10b- hexahydro- 4- propyl- 2H- naphth[1,2- b]- 1,4- oxazin- 9- ol
|
ChemIDplus
|
dopazinol
|
ChemIDplus
|
nazagolide
|
ChemIDplus
|
PHNO
|
ChEBI
|
88058-88-2
|
CAS Registry Number
|
ChemIDplus
|
10956195
|
PubMed citation
|
Europe PMC
|
11105937
|
PubMed citation
|
Europe PMC
|
15646539
|
PubMed citation
|
Europe PMC
|
15943487
|
PubMed citation
|
Europe PMC
|
1681090
|
PubMed citation
|
Europe PMC
|
1840645
|
PubMed citation
|
Europe PMC
|
19635669
|
PubMed citation
|
Europe PMC
|
2140595
|
PubMed citation
|
Europe PMC
|
24325578
|
PubMed citation
|
Europe PMC
|
2904649
|
PubMed citation
|
SUBMITTER
|
3758188
|
PubMed citation
|
Europe PMC
|
6433000
|
PubMed citation
|
Europe PMC
|
8078498
|
PubMed citation
|
SUBMITTER
|
8301582
|
PubMed citation
|
Europe PMC
|
|